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Epidemiological Accountability: 
Philanthropists, Global Health and the Audit of Saving Lives 
 
 
 
 
 
        ‘In God we trust; everyone else bring data’  
 
     – Michael R. Bloomberg 
Entrepreneur, public servant, philanthropist 
 
 
 
 
 
Abstract 
 
There have been concerns about the recent private turn and re-emergence of philanthropies in world health, with many 
worrying about philanthropies’ perceived lack of transparency and accountability. In contrast, I argue that while the 
private turn might have led to a decline in democratic or public accountability, it did not bring an end to all forms of 
accountability. Specifically, I suggest that philanthropists’ involvement in global health has led to the spread of another, 
new form of accountability: epidemiological accountability. The latter is a combination of two regimes of expertise and 
practices hitherto kept separate: audit and epidemiology. To substantiate this argument, I draw on my research on the 
Bloomberg Initiative – a global effort to reduce tobacco use spearheaded by the Bloomberg and Gates foundations.  
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Introduction 
 
The shift from international to global health at the turn of the twenty-first century has 
been characterised by a private turn and the re-emergence of philanthropic foundations 
as major actors in world health, a trend symbolised by the Gates Foundation (Brown et al., 
2006; Rushton and Williams, 2011; Reubi, 2016a). Many commentators have welcomed the 
arrival of these new actors, arguing that they bring with them much needed additional 
funding, a dynamic entrepreneurial spirit and innovative approaches from the business 
world (e.g. Bishop and Green, 2008; Moran and Stevenson, 2013). Others have been less 
sympathetic, levelling a range of critiques against the newcomers (e.g. McCoy et al., 2009; 
Birn, 2014; McGoey, 2015). One particularly important concern for these critiques has been 
private foundations’ perceived lack of transparency and accountability. They point out 
how decisions about what should be funded and why are made by a small, restricted group 
of people behind closed doors. This, they argue, is problematic given the growing power 
of foundations in global health. It also begs the question of what interests are being 
pursued by this small group of people, many of whom come from the pharmaceutical 
industry. These critiques also stress how private foundations not only make little effort to 
engage in dialogue with experts and the public but actually actively discourage debate by 
promoting uncritical groupthink among global health specialists and officials.  
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This article takes a different line. It argues that while the re-emergence of foundations in 
world health might well have led to a decline in what Rushton and his colleagues (2011, 
pp.18 & 157) call ‘democratic’ or ‘public accountability’, it would be mistaken to think that 
it has brought an end to all forms of accountability.1 Specifically, the article suggests that 
the growing involvement of philanthropists in global health has led to the emergence and 
spread of another, new form of accountability, which I term epidemiological accountability. 
This new form of accountability is the result of the coming together of two regimes of 
expertise and practices that were hitherto kept separate. The first is contemporary 
cultures of audit. A collection of reporting routines, performance indicators, accounting 
firms and management experts, these cultures were progressively articulated in the 
twentieth century to govern commercial life before being redeployed to administer public 
life under the banner of New Public Management (Power, 2007; Shore and Wright, 2015). 
The second regime is the forms of knowledge and techniques associated with modern 
epidemiology. These forms – from vital registration systems and health surveys to national 
statistics agencies and epidemiologists – were articulated from the 19th century onwards 
as part of the biopolitics of population that characterises most modern societies 
(Desrosières, 1998; Foucault, 1998).  
 
To develop and substantiate this argument, the article draws on extensive, multi-sited 
archival and field work on the Bloomberg Initiative – an international effort spearheaded 
by Bloomberg Philanthropies and the Gates Foundation to reduce tobacco use in the 
developing world.2 After giving a short account of the Bloomberg Initiative, the article 
goes on to identify and analyse how the expertise and practices of audit and epidemiology 
shape and inform the design and administration of the Initiative. It also explores the ways 
in which the expertise and practices of audit and epidemiology combine in the overall 
assessments and public presentations of the Initiative carried out by both the Bloomberg 
and Gates foundations at regular intervals. Moreover, the article also studies some of the 
pathways along which the values and methods developed by both Bill Gates and Michael 
Bloomberg in their businesses have spilled into their philanthropic work and led to the 
emergence of epidemiological accountability. 
 
 
The Private Turn in Global Health and the Decline of Democratic Accountability 
 
The last twenty years have seen a profound rupture in the organisation and management 
of world health, marked by the shift from international to global health (Brown et al., 2006; 
Gaudillière, 2014; Reubi, 2016a). Starting in the 1990s, a growing number of international 
policymakers, development bureaucrats and public health experts began to increasingly 
talk about ‘global health’ instead of ‘international health’ or ‘health development’. 
Drawing on the globalisation theories that were then predominant, these commentators 
believed that the world was undergoing a process of economic, political and social 
integration. For them, trade liberalisation and a revolution in communication and 
transportation technologies were leading to ever growing flows of information, goods, 
capital and people across political and geographical boundaries. Inherent to these 
processes of globalisation, they warned, were new types of threats to human health, from 
the rapid propagation of infections enabled by affordable air travel to the global spread of 
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fast foods, alcohol and cigarettes made possible by the abolition of trade barriers. For 
these commentators, the existing international health architecture centred on the nation-
state was not equipped to deal with these new problems. Indeed, their transnational 
nature meant that these new types of threats were immune to the efforts of individual 
nation-states and required new, global forms of thought and action. These included global 
legal norms like the WHO’s Framework Convention on Tobacco Control, new international 
financing mechanisms like the Global Fund to Fight AIDS, Tuberculosis and Malaria and 
global epidemiological data like the Global Burden of Disease estimates. 
 
The incapacity of the nation-state to deal with the new health threats associated with 
globalisation was, in the eyes of these commentators, further compounded by the wider 
critique of the state as incompetent and wasteful articulated by neoliberal thinkers in the 
latter half of the twentieth century (Reubi, 2013; 2016b). This led them to promote not only 
new global forms of action, but also interventions by non-state (or private) actors like non-
governmental organisations, public-private partnerships and, importantly for us, 
philanthropies. Of course, as the work of the Rockefeller Foundation’s International 
Health Division during the first half of the twentieth century reminds us, the involvement 
of philanthropies in the administration of world health is not new (Farley, 2004; Birn, 2014). 
However, the private turn that seems so characteristic of contemporary global health has 
certainly led to the re-emergence of philanthropic foundations as major actors in world 
health (Rushton and Williams, 2011; Youde, 2013). The creation of the Bill and Melinda Gates 
Foundation in the early 2000s is perhaps the most visible sign of this recent trend, but 
there are many other philanthropies that are active in global health today, from the Carso 
Health Institute established by Mexican billionaire Carlo Slim to the Clinton Foundation and 
Bloomberg Philanthropies. These philanthropic organisations have been highly influential 
in world health over the last fifteen years, funding biomedical research, launching public 
health initiatives, reconfiguring overseas health development aid and brokering new 
alliances between international organisations, the pharmaceutical industry, governments 
and NGOs (Youde, 2011; Moran and Stevenson, 2013; McGoey, 2014).  
 
Predictably, the literature is divided on the advantages and drawbacks associated with 
foundations’ growing influence in world health. Some commentators have celebrated the 
arrival of these new actors, claiming that they ‘have added dynamism, credibility and 
attractiveness to global health’ (Lancet, 2009, p.1577; e.g. Bishop and Green, 2008; Moran 
and Stevenson, 2013). When discussing foundations’ contributions to global health, they 
generally mention the increased sources of funding, a new entrepreneurial spirit 
concerned with efficiency, learner, more flexible decision-making structures and 
innovative approaches imported from the business world. Others commentators have 
been more critical of philanthropies’ contributions to global health (e.g. McCoy et al., 2009; 
Birn, 2014; McGoey, 2015). Some of these critiques believe that the work of foundations in 
global health is an attempt by business elites to ‘cover for the deleterious effects of global 
neoliberal capitalism’ (Youde, 2013, p.14). Many also argue that, unfortunately, 
philanthropists tend to favour ‘biomedical and largely pharmaceutical-based responses to 
global health problems’ that ignore the underlining social determinants of diseases and 
pay little attention to the local context (Rushton and Williams, 2011, p. 10; see also: Birn, 
2014). 
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More significantly for the argument attempted here, these critiques have complained that 
foundations ‘lack transparency and accountability’ (McCoy and McGoey, 2011, p.152), with 
some even claiming that philanthropies are ‘among the most unaccountable organisations 
in democratic societies’ (Hesselmann, 2011, p.236). To start with, they point out how, in 
most foundations, decisions about what is a funding priority, who to partner with and why 
are ‘in the hands of very few’ people and made ‘behind closed doors, hidden from the 
public’s eye’ (Stuckler and Siegel, 2011, pp.136 & 139). Given the growing power of 
foundations in the field of global health, the secret nature of this decision-making process 
and the restricted number of those influencing it have generated serious anxieties among 
critical commentators. So, for example, the editors of The Lancet (2009, p.1577) have 
recently complained about the opacity and arbitrariness of the principles guiding the work 
of the Gates Foundation: 
 
There is also a serious anxiety about the transparency of the Foundation’s operation. 
What are the Foundation’s future plans? It is hard to know for sure. The first guiding 
principle of the Foundation is that it is ‘driven by the interests and passions of the Gates 
family’. An annual letter from Bill Gates summarises those passions referring to 
newspapers, articles, books and chance events that have shaped the Foundations’ 
strategy. Is such a whimsical governance principle good enough? 
 
Similarly, others have expressed concerns about whose interests are being served by the 
select few who take the decisions for private foundations. Thus, sociologist Linsey McGoey 
(2015) has queried whether the strong presence of former drug industry executives among 
the decision-makers at Gates has contributed to the foundation’s bias for pharmaceutical 
solutions, while political economist David Stuckler (2011) has suggested there could be a 
link between Gates’ refusal to tackle non-communicable diseases and the foundation’s 
substantial investment in Coca-Cola and other corporate giants of the agro-food sector.3 
Furthermore, those critical of philanthropies’ lack of transparency and accountability also 
point out that private foundations make little effort to engage in dialogue with and 
respond to constructive criticism from experts in the field, grant recipients and the general 
public. As political scientist Jeremy Youde (2011, p.176) explains in his study of the Clinton 
Foundation:   
 
[Private philanthropies] have disproportionate influence, yet the public has next to no 
opportunity to express its opinions or voice concerns about their programmes. They 
replace a mass democratic voice with a top-down autocratic one … [There are no] 
opportunities for both donors and recipients to voice their concerns and … engage in 
public dialogue about priorities and appropriate approaches … Private philanthropies 
like the Clinton Foundation … assume the voice of those they claim to represent 
instead of allowing them their own voice. 
 
Moreover, these critiques claim that, not content with failing to generate avenues for 
dialogue, many foundations are actively ‘discouraging debate’ by ‘creating a cartel 
mentality’ and ‘promoting groupthink’ among global health expert and officials (Youde, 
2013, p.13). For example, global health expert and physician David McCoy (2011, p.153) has 
described how, by aggressively pushing its own agenda, the Gates Foundation has led to 
‘self-censorship and the stifling of diverse views among scientists’ who are now afraid to 
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voice any sort of criticism for fear of being denied any funding (see also: Stuckler and Siegel, 
2011; Birn, 2014). For these critiques, this lack of accountability and transparency of private 
foundations in the field of global health ‘represents a significant challenge to democracy 
and principles of good governance’ (McCoy and McGoey, 2011, p.157). To address this issue, 
they have been repeatedly calling for the adoption of better mechanisms of public 
accountability and standards of transparency. So, for example, the editors of The Lancet 
(2009, p.1577) implored the Gates Foundation to: 
 
Improve your governance. Visibly involve diverse leaders with experience in global 
health in your strategic and operational stewardship … Be more transparent and 
accountable in your decision making … Listen and be prepared to engage with your 
friends.  
 
 
Epidemiological Accountability 
 
While the private turn and re-emergence of foundations in world health might well have 
led to a decline in this type of ‘democratic’ or ‘public accountability’ (Rushton and Williams, 
2011, pp.18 & 157), it would, however, be a mistake to think that it has brought an end to 
all forms of accountability. Indeed, as I suggest here, the growing involvement of 
philanthropists like Bloomberg and Gates in global health has led to the emergence and 
spread of another, new form of accountability, which I term epidemiological accountability. 
As the article describes in more detail below in relation to the Bloomberg Initiative, this 
new form of accountability brings the expertise and practices of audit together with those 
of modern epidemiology. 
 
As Michael Power (1997) and others (e.g. Strathern, 2000; Merry, 2011; Shore and Wright, 
2015) have argued, the expertise and practices of audit – reporting and verification 
procedures; performance indicators; accounting experts; management firms – have 
become central to the government of life. Progressively articulated during the twentieth 
century as part of attempts to protect investors against fraud and efforts to improve 
productivity and product quality, these forms of expertise and practices were initially 
primarily concerned with the management of commercial and corporate life. It is only from 
the 1980s onwards that, spurred by New Public Management theories, they spilled into 
and re-shaped the organisation and administration of public life, from education and 
healthcare to scientific research and international development. New Public Management 
theories have also been critical in re-inscribing these forms of expertise and practices 
within a complex web of political values and beliefs. These include demands for fiscal 
restraint, misgivings about the state’s incompetence and a belief in market efficiency, as 
well as appeals for increased accountability and value-for-money.  
 
The expertise and practices of modern epidemiology have a long genealogy (Reubi, 2017). 
An important, early development was the birth of vital statistics in the nineteenth century 
(Szreter, 1991; Desrosières, 1998). This quantitative knowledge about a population’s births, 
marriages and deaths was made possible by a combination of national statistics 
bureaucracies, public health reformers and new quantification practices like vital 
registrations systems and censuses. More generally, it was also made possible by a 
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reconfiguration of political power, from a medieval sovereign concerned with God’s 
natural order to a modern government dedicated to improving the condition of the 
population (Foucault, 2009). Indeed, this new form of power involved a new biopolitics of 
population devoted to fostering biological life and guided by scientific and, especially, 
statistical truth (Porter, 1995; Foucault, 1998). This assemblage of vital statistics and 
biopolitics was partly reconfigured by the rise, in the twentieth century, of surveillance 
medicine articulated around the community dispensary, unhealthy lifestyles and a politics 
of social solidarity (Armstrong, 1983; 1995). Specifically, surveillance medicine spurred a 
shift from the old public hygiene concerned with the environment and infections to the 
new public health focused on individual behaviour and chronic diseases. It also led to the 
development of a new way to conceive and quantify the life of the population – the social 
survey, which measured the biological, social, economic and political dimensions of 
unhealthy lifestyles. A product of the new academic discipline of epidemiology taught at 
public health schools after the 1930s, this new quantification practice was built around 
sophisticated statistical techniques and qualitative sociological methods.  
 
 
The Bloomberg Initiative 
 
To illustrate and further elaborate this new, hybrid form of accountability marrying the 
expertise and practices of audit and modern epidemiology, I draw on my research on the 
Bloomberg Initiative. Whether this epidemiological accountability informs other, similar 
philanthropic global health efforts is something that only further research can tell. But, 
given that the Bloomberg Initiative and other, similar philanthropic efforts share many of 
the same forms of knowledge, institutions and techniques, it is reasonable to expect that 
a similar form of accountability also shapes these other efforts (e.g. McCoy et al., 2013; 
Adams, 2016; Mahajan, 2017). At the very least, one can assume that these other efforts 
are informed by forms of accountability that, to draw from Wittgenstein (2009, p.36), have 
strong ‘family resemblances’ to the epidemiological accountability at work in the 
Bloomberg Initiative. 
 
The Bloomberg Initiative was launched in 2007 by businessman and then mayor of New 
York City Michael Bloomberg and his charity Bloomberg Philanthropies with the aim to 
reduce tobacco use in the developing world (Bloomberg Philanthropies, 2011; see figure 1). 
A year later, the Bill and Melinda Gates Foundation became an official partner of the 
Initiative, adding an extra US$125 millions to the almost US$1 billion invested by Bloomberg 
(Gates Foundation, 2015a; Bloomberg Philanthropies, 2016). For Bloomberg and the 
Gateses, the Initiative is part of their wider commitment to ‘give back’ to the community 
and help ‘make a better world’ (Bloomberg, 2001, p.242; Gates and Gates, 2010, p.2). The 
Initiative builds on the anti-smoking campaign that the then New York Health 
Commissioner Tom Frieden and his team ran in the city during Bloomberg’s mayoralty. For 
Bloomberg and Frieden, who had been tasked by the Mayor with designing the Initiative, 
the latter was a great opportunity to showcase their work in New York at a time when, 
following the adoption of the WHO Framework Convention on Tobacco Control, there was 
growing momentum in the international fight against smoking (Reubi and Berridge, 2016). 
In keeping with Frieden’s original blueprint, the Initiative comprises three hierarchically-
ordered groups of organisations. At the apex are the Bloomberg and Gates foundations, 
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whose experts decide the overall strategy, objectives and funding allocation. It is, for 
example, these experts who determined that the initiative should focus on a well-defined 
package – the so-called MPOWER package – of tobacco control policies that included: 
advertising bans; smoke-free environments; cessation programmes; tobacco taxation; 
public health campaigns; and warning labels (WHO, 2013a, 2013b). At the bottom are local 
advocacy groups and government agencies whose role is to ensure that these policies are 
put in place and implemented. In the middle are a small number of privileged partners that 
act as a sort of relay between the two philanthropies and the local organisations. These 
privileged partners include the WHO’s Tobacco Free Initiative, the US Centres for Disease 
Control (CDC), the Johns Hopkins’ School of Public Health, and some, mostly American 
charities like the Campaign for Tobacco Free Kids, the International Union against 
Tuberculosis and Lung Disease and, to a lesser extent, the American Cancer Society (Gates 
Foundation, 2009; Bloomberg Philanthropies, 2011). The role of these organisations, 
whose tobacco control work is directly funded by Bloomberg and Gates, is two-fold: set 
up a global monitoring system to track the evolution of tobacco use and tobacco control 
policies; and support the work of local organisations through technical assistance, capacity 
building and small grants programmes. 
 
[Insert Figure 1 here] 
 
 
Expertise and Practices of Audit 
 
As with some other philanthropic efforts (e.g. Youde, 2013; Adams, 2016; Mahajan, 2017), 
the expertise and practices of audit powerfully inform the organisation and management 
of the Bloomberg Initiative. Grantees working for the initiative repeatedly noted this fact 
in our interviews: 
 
The Americans [Bloomberg and Gates] love accountability, a lot of it. Accountability 
and transparency the whole nine yards. So, you need to check that your story is actually 
straight. 
 
The Bloomberg people are just here all the time, reviewing and checking our work all 
the time.  
 
Reporting routines are an important aspect of the audit culture at work within the 
Bloomberg Initiative. The organisations that receive funds from the Initiative, either 
directly from the Bloomberg and Gates foundations or indirectly via the small grants 
schemes managed by the privileged partners, are required to report on a regular basis. 
While exact reporting requirements can vary from one scheme to another, the general 
pattern is the same throughout the Initiative. For each project, grantees will have to deliver 
monthly written activity reports, quarterly intermediary written reports and one final 
written report. In addition, grantors will phone grantees up to twice a week to ask for oral 
updates on the project. As a seasoned grant administrator in the field explained to me, this 
amount of reporting is exceptional: 
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Bloomberg is a unique donor. Most traditional donors, I mean development agencies 
like USAID, they kind of write a cheque and say: ‘tell us in a year what happens’. 
Bloomberg are sitting in our laps all the time. They are right in everybody’s face always. 
We report quarterly on our budget which is not the case for any other donor. We have 
monthly reports back to them on all of our capacity building and technical assistance 
that we’re doing. We have annual reports to do. I’m on the phone with them ten times 
a month. It is a very unusual relationship for us. It has been a bit of a culture shock. 
 
The reports will generally comprise two types of information. First, they will contain 
financial information, including a budget indicating the money spent to date together with 
the original receipts and invoices. Second, the reports will also contain information on all 
the grantees’ activities that are relevant to the project: the studies commissioned and the 
experts consulted; the total of information leaflets printed and distributed; the number of 
workshops organised and the people trained; the lobbying activities from phone calls to 
journalists to courtesy visits to politicians; and so on. To ensure that this information is 
collected, grantees are required to record any relevant activity on ad hoc log sheets, which 
generally contain a series of boxes to mark the date, describe the activity, indicate the 
people involved, explain how successful it was and discuss what will be done next (see 
figure 2). As one grantee explained: 
 
We have these reporting logs. There is a log for industry monitoring, one for project 
progress, one for courtesy calls, one for the status of the law, oh there are so many 
logs … For accountability and for follow up you keep filling in these logs. So, I go to 
see this MP, he said X and Z, you fill it in. Or, there was this tobacco industry 
interference that was reported in the media today, this is how we would want to 
counter it. Or you did a workshop, you write in the log how many people you called, 
how many emails you sent, how many persons attended. It’s quite a bit of work … But 
it helps you remember things and makes writing the reports much easier. 
 
The reports allow grantors to monitor the project’s progress and check whether the key 
milestones identified in the grant agreement are being achieved. In the world of the 
Bloomberg Initiative, it is only if these milestones are achieved that the next tranche of 
funding can be disbursed. The reports also allow grantors to identify a problem early on 
and attempt to rectify it, be it by providing technical assistance or extra training, allowing 
the reallocation of an unspent budgetary post to another task or agreeing to a no-cost 
extension. It is only if nothing can be done to rectify the problem that grantors will 
consider terminating a project, something that happens surprisingly rarely. 
  
[Insert Figure 2 Here] 
 
Some of these same functions are also fulfilled by another important element of the 
Bloomberg audit culture: the inspection. At regular intervals, grantors will send out 
independent auditors to carry out onsite visits to inspect grantees and evaluate their 
projects. A key purpose of these visits is to meet grantees, check their organisations’ 
financial management and operational systems and teach them about the funder’s 
procedures. As one auditor explained to me:  
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A site visit is … the chance to meet the grantees. Just walk around the office and 
familiarise ourselves. Know that we are working with a bona fide partner … It is about 
assessing the organisation’s finance management system, to ensure it is effective, 
efficient. We audit their reports, the time sheets, rental agreements, accounting 
system. We check receipts, the work plan, the budget, that everything is in order … 
We check how they manage the office, how they file and send documentation, etc. It 
is also a capacity building moment, to tell them about our procedures.  
 
Another aim of these audits is to verify the activities reported by the grantees, as one 
grantee explained to me:  
 
They sent someone to evaluate my report. And they said: ‘Oh you said you worked with 
these people, can we talk to them?’ … So, I took them around to about thirteen major 
partners – ministry of health, journalists, civil society, members of parliament – who I 
said I had been dealing with in my reports. Then they talked to them and asked: ‘Is it 
true?’ 
 
The audit culture that informs the Bloomberg Initiative also brings with it accountants and 
management specialists – novel forms of labour and expertise in the field of international 
tobacco control that was, until then, dominated by physicians, public health specialists, 
lawyers, economists and anti-smoking activists (Reubi and Berridge, 2016). To start with, 
grantors generally use management experts and accountants to check the reports sent by 
the grantees and carry out onsite inspections. So, for example, the American Cancer 
Society hires an external consultant, a small accountancy and project management firm 
based in Nairobi, to audit its grantees working on tobacco control in Africa. Likewise, most 
project management and financial compliance officers working for either the American 
Cancer Society or the Campaign for Tobacco-Free Kids have a formal training in business 
studies or development management. Moreover, grantors strongly encourage grantees 
to hire professional accountants and to acquire themselves basic project management 
skills by taking some relevant courses. As one grantor pointed out: 
 
Our grantees are great [tobacco control] advocates but they often have no idea how 
to do any kind of business or accounting or office management. When we note this 
during an inspection, we recommend that they hire an accountant or an office manager. 
Or we encourage them to undergo some kind of training in project management. And 
we provide them with the necessary extra funding to do this. As a result, they’ve really 
grown in terms of their capacity for managing money and managing projects. In terms 
of being a real organisation.  
 
 
Expertise and Practices of Epidemiology 
 
The design and management of the Bloomberg Initiative is permeated not only by the 
expertise and practices of audit but also by the ones of modern epidemiology. A clear sign 
of the centrality of epidemiological expertise and practices for the Initiative is the critical 
part played by professional epidemiologists in devising and administrating it. Tom Frieden 
and Kelly Henning, two medical doctors trained in epidemiology at the CDC, are exemplary 
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in that respect: as mentioned earlier, Frieden, now Director of the CDC, was in charge of 
setting up the Initiative when he was Health Commissioner of New York City; and Henning, 
as Director of International Health Programmes at Bloomberg Philanthropies, helped 
Frieden design the Initiative and now directs it (Frieden and Bloomberg, 2007). Likewise, 
Kathy Cahill, a public health specialist who worked as Director for Planning, Policy and 
Evaluation at the CDC, was responsible for devising the Gates Foundation’s tobacco 
control strategy and partnership with the Bloomberg Initiative. 
 
It is these and other epidemiologists who, applying their knowledge and methods, 
translated Bloomberg and Gates’ desire to save lives into a project with a clear focus, 
strategy and targets (Gates Foundation, 2009; Bloomberg Philanthropies, 2011). To start 
with, they suggested focusing the Initiative on tobacco use, pointing out that recent 
epidemiological studies like Christopher Murray’s work on the Global Burden of Disease 
and Richard Peto’s analyses on global smoking-attributable mortality showed that tobacco 
was now the leading cause of death worldwide (e.g. Peto and Lopez, 2000; Mackay and 
Eriksen, 2002; Lopez et al., 2006). As two epidemiologists involved in the design of the 
initiative recalled: 
 
The decision to focus on tobacco came entirely from the data ... We were looking for 
an area related to a very large number of deaths worldwide ... So, we looked at the 
numbers and analysed them. They showed that smoking was now the world’s leading 
single cause of death with over six million deaths per year compared with three for 
AIDS, two for tuberculosis, one for malaria … We knew our focus had to be tobacco.  
 
Bill Gates was convinced by the numbers. He has a very mathematical mind. He just 
read all the information. He read the Global Burden of Disease. He read the Tobacco 
Atlas ... And he did the maths. He saw the number of lives that can be saved. That is 
why he became interested in tobacco and teamed up with Bloomberg. 
 
By making clear that the smoking epidemic was concentrated and rapidly expanding in the 
developing world, the same studies also convinced epidemiologists working for 
Bloomberg and Gates that the initiative should centre on low- and middle-income 
countries (Reubi, 2016a). Similarly, they made it possible for these epidemiologists to 
compute the Initiative’s overall target of reducing the global smoking prevalence rate 
below 20% and ‘preventing 100 million deaths’ by the year 2020 (Frieden and Bloomberg, 
2007). In the same way, Tom Frieden and his colleagues decided to make the MPOWER 
policies the focus of the Bloomberg Initiative because they had been proved to be 
‘effective’ by public health research (Frieden and Bloomberg, 2007; Gates Foundation, 
2009).  
 
[Insert Figure 3 here] 
  
The epidemiologists who helped devise the Bloomberg Initiative also played a key role in 
setting up a global surveillance and monitoring system to follow the Initiative’s progress. 
As one of these epidemiologists clarified for me, the system is built around ‘two major 
measurement strategies’. The first is the Report on the Global Tobacco Epidemic (GTER). 
Compiled by the WHO every two years, the report monitors the worldwide progress of 
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tobacco control policies by counting the number of countries who have implemented and 
the percentage of the globe’s population covered by at least one of the MPOWER policies 
(WHO, 2009; 2011; 2013a; see figure 3). The second is the Global Adult Tobacco Survey 
(GATS). Run by the CDC in collaboration with national statistic agencies, the GATS is a 
household survey that monitors adult tobacco use and tracks key tobacco control 
indicators such as smoke-free environments and advertising bans (CDC, 2009). At the time 
of writing, the GATS, in either its full or abridged version, had been completed once in 
about 70 countries and repeated a second time in 2 countries (CDC, 2015). The longer-term 
aim, of course, was to have an ever larger number of countries carrying out the GATS at 
regular intervals to make it possible to trace the fluctuation in tobacco use across the globe 
and over time. For Frieden and his colleagues, this two-fold surveillance and monitoring 
system was deemed critical for the effective management of the initiative. They believed 
that such a system was critical to determine whether the strategies used were working 
and whether the targets identified were being reached. As they explained in an 
information leaflet:  
 
Surveillance and monitoring are important public health … tools. They provide critical 
information to strengthen programmes and policies, and to evaluate their 
effectiveness. ‘If you can’t measure it, you can’t manage it’ (CDC, 2011, p.1). 
 
 
Combining Audit and Epidemiology  
 
It is standard policy for both the Bloomberg and Gates foundations to continually evaluate 
the projects in which they invest. When describing their ‘approach’ to giving in their 
publications, Bloomberg Philanthropies (2015, p.7) always stress the value they attach to 
‘continually measur[ing] progress’. Likewise, the Gates Foundation (2015b, p.1) 
emphasises in its policy documents that ‘achieving our ambitious goals requires rigorous 
evaluation so we and our partners can continually improve’. It is this shared evaluation 
policy that has led the two philanthropies to regularly assess the Bloomberg Initiative and 
its overall impact. As one of the experts working for the Initiative explained to me in an 
interview, these regular assessments are ‘about accountability and good governance’. 
More specifically, they enable the two foundations to determine progress and analyse 
what is working and what is not and needs to be adjusted in order to improve the 
Initiative’s overall impact. As Bloomberg Philanthropies (2013, p.3) explain, we need ‘to 
harness the power of data’ to ‘understand impact, evaluate results and improve 
performance’. In a similar spirit, the Gates Foundation (2015b, pp.2-3) explains that: 
  
Evaluation [is] a collaborative learning tool that provides us and our partners with 
feedback so we can learn, adjust and decide how best to achieve outcomes … [It] 
provides feedback on what is and is not working. 
 
In addition, the regular assessments carried out by the two foundations also provide them 
with the necessary information to showcase their work to the global health community 
and beyond in annual reports, public presentations and media briefings (e.g. Bloomberg 
Philanthropies, 2011; 2015).  
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[Insert Figure 4 here] 
 
Both the Bloomberg and the Gates foundations like to think of their evaluation protocols 
as quasi-scientific processes characterised by systematicity, objectivity and rigour. So, for 
example, in an interview with me, an expert at Bloomberg Philanthropies explained that 
the regular assessment of their projects was based on ‘very rigorous monitoring and 
surveillance’. Likewise, in a recent document on its evaluation policy, the Gates Foundation 
(2015b, p.1) suggests that an evaluation is a ‘systematic, objective assessment of an 
ongoing or completed project or partnership’. The same document also indicates that an 
evaluation will draw on ‘many different types of evidence’, including: ‘partner monitoring 
data, grantee reports, modelling, population-level statistics and other secondary data’ 
(ibid., p.3). This is certainly characteristic of Bloomberg and Gates’ regular assessments of 
the Initiative, which are built around a combination of various forms of evidence 
associated with the expertise and practices of audit and epidemiology outlined earlier, 
including grantees’ reports, the GATS and the GTER. In official documents and 
presentations, these different forms of evidence are generally organised in three separate 
categories. The first category is ‘investments’ and generally corresponds to the total 
amount of money that Bloomberg and Gates have poured into the initiative. So, for 
example, in one of its earlier report on the Initiative, Bloomberg Philanthropies (2011, pp.1 
& 11) reminded readers that it had made ‘a $375 million investment’ to which Gates had 
added a ‘commitment of $125 million’. The second category is ‘actions’ which is the 
summation of all the different activities carried out and recounted by grantees in their 
reports. As a senior public health expert from Bloomberg Philanthropies elaborated during 
a presentation (see figure 4) to a group of grantees:   
 
When we are reporting back to Mike [Bloomberg] about our progress and our success 
in the Initiative … we talk about the training of journalists and how many stories have 
come out in support of tobacco control around the world; we look at all of the efforts 
you were involved in; and we count all of these on a regular basis. 
 
A good illustration of these counting practices can be found in a recent Bloomberg 
Philanthropies’ (2011, p.14-25; see figure 5) publication:  
 
To date, 300,000 individuals … have completed the GATS … Funded partner 
organizations and in-country grantees [have]: …completed air quality monitoring 
studies in 34 countries; … developed a technical guide … [on] warning labels; launched 
64 anti-tobacco … mass media campaigns in 18 countries, viewed by 643 million 
people; … conducted workshops with journalists from 28 countries on tobacco control 
issues; … provided legal expertise … [in] 55 countries; …[and] published 13 white 
papers on tobacco economics. In addition, … almost 300 senior-level government and 
civil society representatives from 34 countries having been trained through an annual 
intensive leadership program for tobacco control [and] more than 5,000 [individuals] 
from 172 countries participated in a free online training. 
 
[Insert Figure 5 here] 
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The third and last category are ‘outcomes’ or ‘impacts’. As an epidemiologist working for 
the Initiative explained to me, the ‘ultimate impact is reducing deaths’. In the absence of 
reliable data on global smoking-attributable mortality, the Initiative uses computer 
simulation models, such as the ‘SimSmoke’ model elaborated by American economist 
David Levy and his colleagues, to estimate the number of lives saved through its 
investments and activities (e.g. Levy et al., 2013; Dubray et al., 2015). These models start 
with the numbers of activities reported by grantees and two measures of intermediate 
impacts – the number of countries that implemented one or more MPOWER policies, as 
measured by the WHO’s GTER; and global smoking prevalence, as measured by the CDC’s 
GATS. From there, they estimate the amount of lives saved using a combination of 
assumptions about the effectiveness of single tobacco control policies, counterfactual ‘no-
intervention’ or ‘status quo’ scenarios and baseline data on mortality rates and relative 
risks of death (Levy et al., 2002; McCoy et al., 2013). Usually, these models and the causal 
links between investments, activities and outcomes are taken for granted by experts 
working for the Initiative. So, for example, in the presentation to grantees mentioned 
earlier (see figure 4), the senior expert from Bloomberg Philanthropies began by 
reiterating the amount of money invested by Bloomberg and Gates, then enumerated 
some of the activities carried out as part of the Initiative and, in conclusion, stated that: 
 
We have made quite a bit of progress in the eight years since we started. We have had 
quite an impact. There has been a lot of success in recent years as the growing numbers 
of countries having adopted one MPOWER policy shows … And we estimated that the 
lives saved based on the policy progress we have made … We had expected some 
increases … but we were absolutely astounded … to see that all the policy progress 
made … had doubled our lives saved estimates, from 7 to 14 million. 
 
While the aim of this article is not to expose the shortcomings of the quantification 
techniques used in the Bloomberg Initiative, it is still worth noting here that the 
methodology and computer simulation models underpinning ‘saved lives’ metrics are not 
without problems. Indeed, as McCoy and colleagues (2013, pp.2 & 5) have showed in 
relation to The Global Fund to Fight AIDS, Tuberculosis and Malaria, such metrics tend to 
be ‘overestimates’ because of the many ‘extrapolations, assumptions and generalisations’ 
on which they are based (see also Levy et al., 2013; Dubray et al., 2013). To start with, McCoy 
and colleagues point out that the numbers that are entered into the models and serve as 
the base for computing ‘saved lives’ metrics – that is, in the case of the Initiative, the 
numbers of activities reported by grantees, the laws adopted as per the GTER and the 
smoking prevalence as per the GATS – are often inflated. Indeed, given the predominance 
of ‘performance-based funding models’ in private-public global health ventures such as 
the Initiative, grantees ‘have strong incentives to over-report their performances’ (McCoy 
et al., 2013, p.2). Furthermore, ‘saved lives’ metrics tend to be too high because the 
estimates about the effectiveness of the public health interventions used – that is, in the 
case of the Initiative, estimates of the power of MPOWER policies – are too optimistic. This 
can be due to different reasons, including: estimates being ‘derived from small-scale 
studies’ where the quality of interventions is ‘better than in real-world settings’; and a 
failure to factor in variations associated with different political, cultural and economic 
contexts or adjust for ‘different baseline mortality rates’, ‘patterns of disease’ and ‘relative 
risks of death’ (Levy et al., 2013, p.515; McCoy et al., 2013, pp.2-3). Finally, when there is a 
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range of projects supporting similar public health interventions – as is the case in tobacco 
control, where the Initiative is one among a variety of other local, national and global anti-
smoking efforts – there is a risk of double-counting and incorrectly attributing to oneself 
the lives saved thanks to the work of others.  
 
 
Epidemiology as the New Bottom Line 
 
The values and practices developed by Bill Gates and Michael Bloomberg in their business 
ventures, their philanthropic work and, for Bloomberg, in public service offer insights into 
how audit and epidemiology, both alone and in combination, became central to the 
management of the Initiative. For both Gates and Bloomberg, information or data has 
been at the heart of their work at Microsoft Corporation and Bloomberg L.P. respectively. 
To start with, information and information technology was central to what their 
companies did. Writing in the 1990s, Gates (2008a, pp.1, 4 & 32) thought that the world 
was ‘moving into the information age’: a new, ‘exciting time’ when personalised 
computers and the internet – the ‘information highway’ – would make it possible to 
produce, store, analyse and transmit ever ‘more data’, thus revolutionising every aspect 
of society, from business and government to healthcare, education and the home. He 
rightly viewed the work he and his colleagues were doing at Microsoft – developing 
programming languages, operating systems and other programmes – as a key driver of 
this revolution (Gates, 2008a; 2008b). Bloomberg, too, played an important role in the 
making of this new information age. Having started by selling financial data and analytical 
software through its own computer terminals, Bloomberg L.P. later expanded to become 
a world leader in the field of financial and business information (Bloomberg, 2001; Brash, 
2011).  
 
Moreover, echoing the cultures of audit deployed in the administration of commercial and 
corporate life in the twentieth century, Gates and Bloomberg also understood information 
as critical to good management and a successful business. Gates, in particular, was often 
viewed as ‘one of the high priests’ of this new culture of audit ‘built around the massive 
gathering and meticulous analysis of numerical data’, with managers at Microsoft 
expected to ‘crunch numbers for everything before they made decisions’ and ‘deliver 
quantifiable results for each dollar spent’ (Smith 2015, p.148). For Gates (2008b, p.4), 
‘success’ in business ‘followed from positive leadership based on information and reason’. 
Good management, in other words, entailed the building of a complex ‘infrastructure’ to 
thoroughly and rigorously gather and analyse data about every aspect of one’s business – 
from ‘information about product design and development’ and ‘marketing, sales and 
supplies’ to information ‘about payments and finance’ and ‘customer service’ (ibid, p.6). 
As Gates (2008b, pp.62-63) further explained: 
 
Know your numbers is a basic business principle. You need to gather your business’s 
data at every step of the way and in every interaction with your customers – and with 
your partners, too. Then you need to understand what the data means … If you do not 
understand what is happening in your business factually, and you are making decisions 
based on soft data or emotion, you will eventually pay a big price. Numbers give you 
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the factual basis for the directions in which you take your products …They help you 
identify your highest priorities. 
 
Bloomberg had very similar values and beliefs, repeatedly stressing that ‘following the 
data’ was the motto at the heart of his company and famously stating that: ‘In God we 
trust; everyone else bring data’ (Bloomberg Philanthropies, 2012, p.3). 
 
Unsurprisingly perhaps, Gates and Bloomberg brought their belief in data and audit that 
has been so central to their businesses over into their philanthropic work. Discussing the 
similarities and differences between his work at Microsoft and running a foundation, Gates 
declared that many of the lessons he had learned in business and, especially, his concern 
with data and measurement would apply to philanthropy: 
 
The common sense of the business world, with its urgency and focus, has strong 
application in the philanthropic world. I am sure I will make mistakes in over-applying 
some elements from my previous experience and will need to adjust … However, I am 
equally confident that our maniacal focus on … measuring results will make a 
difference (Gates, 2009, p.2). 
 
You can achieve amazing progress [in your philanthropic endeavours] if you set a clear 
goal and find a measure that will drive progress towards that goal … Given a goal, you 
decide on what key variable you need to change to achieve it – the same way a business 
picks objectives for inside the company … – and develop a plan for change and a way 
of measuring the change. You use the measurement as feedback to make adjustments 
(Gates, 2013, pp.2-3). 
 
Bloomberg was, if anything, even more confident about applying the insights he picked up 
in his business and, specifically, his belief in data and evaluation to his philanthropic work: 
 
Data is the driving force behind my company’s value to the financial services industry … 
Bloomberg Philanthropies is no different. It harnesses the power of data to assess 
opportunities, understand impact, evaluate results and improve performance 
(Bloomberg Philanthropies, 2012, p.3). 
 
Of course, Gates and Bloomberg were not the only ones applying their belief in the power 
of data and audit acquired in the business world to their philanthropic work. Rather, as 
Matthew Bishop and Michael Green (2008, pp.1-2) have argued, they were illustrative of a 
wider trend whereby ‘today’s new philanthropists are trying to apply the secrets behind 
their money-making success to their giving’ and which they termed ‘philanthro-capitalism’. 
And, what is important for us is that it is as part of this wider trend that a culture of audit 
articulated around reports, evaluations and management experts made its way into the 
Bloomberg Initiative and other philanthropic efforts. To borrow from McCoy and McGoey 
(2011, p.146-147), ‘the application of competitive business skills, acumen, and tactics to 
philanthropy and charitable activities’ has led, among other things, to a ‘greater insistence 
on measurable results and more direct management of grantees by their funders’ (see also 
Rushton and Williams, 2011; Smith, 2015; Mahajan, 2017).  
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It is also because of Gates and Bloomberg’s belief in data and measurement that 
epidemiological expertise and practices become so central to the Bloomberg Initiative. But 
here the precise pathways differ for the two philanthropists. For Gates, epidemiology was 
the response to his search for the ultimate yardstick of success or failure in his 
philanthropic work on global health. Gates quickly realised that while he could transfer the 
techniques of audit like reports, indicators and evaluations from his business to his 
foundation, he could not do the same with the notion of profit. Profit in business was the 
bottom-line, the definitive measure of whether what you did worked or not. The fact that 
it did not apply to philanthropic work was a problem for Gates in so far as he was left 
without any criteria to judge whether his efforts were making a difference or not. As he 
argued: 
 
Unlike business, where profit is the bottom line, foundations … pick their own goals 
[and make that their bottom line] (Gates, 2013, p.2). 
  
[A] way that running a foundation is not like running a business is that you don’t have 
customers who beat you up when you get things wrong or competitors who work to 
take those customers away from you. You don’t have a stock price that goes up and 
down to tell you how you are doing. This lack of natural feedback loop means that we 
as a foundation have to be even more careful in picking our goals and being honest 
with ourselves when we are not achieving them. We work hard to get … feedback. 
(Gates, 2009, p.14).  
 
This explains why the Gates Foundation has spent a lot time and money in identifying clear, 
measurable alternative ‘bottom lines’ to assess its philanthropic investments. In the field 
of education, this has led it to get States in the USA to ‘agree to common rules on how to 
measure graduation rates and on what standards must be achieved to graduate’ (Bishop 
and Green, 2008, p.60). In the field of global health, it has led the Foundation to focus on 
the numbers of lives saved and fund Christopher Murray and his team at the Institute of 
Health Metrics and Evaluation to calculate the global burden of disease and disability at 
regular intervals (Smith, 2015). As Gates explains: 
 
The metric of success is lives saved ... Which is slightly different than units sold [or] 
profits achieved. But it’s all very measurable [through epidemiology], and you can set 
ambitious goals and see how you do (Gates cited in Smith, 2015, p.149).  
 
For Bloomberg, in contrast, his discovery and interest in epidemiology developed during 
his time as Mayor of New York City. As Julian Brash (2011) explains, Bloomberg brought his 
faith in data and evaluation, which he had acquired in his business, with him when he took 
over at City Hall. Inspired by a rhetoric of transparency and efficiency derived from New 
Public Management and seeking to be a ‘CEO Mayor’ as he had promised during his 
electoral campaign, he set up multiple systems to monitor and measure the city’s public 
services. Some of these systems were internal and for the benefit of the administration, 
like the Citywide Accountability Programme, a scheme providing managers information to 
assess and improve their employees’ performances. Others were external and for the 
benefit of citizens. There was, for example, the 311 phone helpline where citizens could 
complain and report problems and which, together with citywide customer satisfaction 
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surveys, generated data about citizens’ level of contentment about municipal services. 
And there was the Mayor’s Public Report Card, an annual report with goals and targets as 
well as indicators and result-oriented statistics demonstrating success or failure. It is as 
part of these efforts at transparency and efficiency at City Hall that Bloomberg started 
engaging with epidemiological expertise and practices. Indeed, his Health Commissioner, 
Tom Frieden, and his team at the Department of Health collected many health statistics – 
including on smoking prevalence and attitudes to tobacco use – which Bloomberg and his 
advisors consulted and integrated in their annual Public Report Cards. From there, 
epidemiological expertise and practices went on to influence the Bloomberg Initiative 
thanks to the central role played by Frieden and others in the design of the Initiative. As 
one expert working for the latter explained, there was a strong alliance between 
Bloomberg and epidemiologists based on their shared belief in data:  
 
Bloomberg is 100% about data. His entire business is built on data. At City Hall he 
implemented all sorts of data-driven initiatives. This is a person very interested in data. 
Similarly, I am a trained epidemiologist and my focus is also on data … We both just 
want to know what impact we are having. That is why we fund measurement strategies 
like the GATS. 
 
 
Conclusion 
 
Contrary to what is often argued in the more critically-minded literature on global health, 
I suggested that philanthropists’ growing influence in the organisation and management 
of world health has not led to the disappearance of all forms of accountability. Specifically, 
and focusing on the Bloomberg Initiative spearheaded by the Bloomberg and Gates 
foundations, I have argued that the increasing involvement of philanthropists in global 
health has led to the development of a new form of accountability – epidemiological 
accountability – which combines the expertise and practices of audit with those of modern 
epidemiology. In these concluding remarks, I want to draw some of the broader 
implications that my argument might have for those of us in the social sciences and 
humanities who work on and write about the languages and cultures of accountability that 
permeate the fields of global health, international development and beyond. 
 
When faced with a new form of accountability like epidemiological accountability, one 
question that some might be tempted to ask is whether this new form of accountability 
works at all. This, I believe, would be asking the wrong question. Indeed, such a question 
fails to unpack the key ideas and practices – the desire to save lives; the drive for 
effectiveness; the trust in numbers; the monitoring systems and evaluation procedures – 
around which epidemiological accountability is articulated. Put differently, to ask such a 
question would mean evaluating whether this new form of accountability really makes 
saving lives and the management of world health more effective, thus very much 
operating from within the epidemiological accountability episteme and reproducing rather 
than interrogating its core assumptions. A more fruitful approach, I suggest, would be to 
ask what does this new form of accountability produce. This question shifts our analytical 
gaze from epidemiological accountability’s possible shortcomings to its performative 
power and the new forms of knowledge and subjectivity it generates (Power, 1997; 
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Desrosières, 2015). As I showed in the article, epidemiological accountability helps create 
many such new forms. A good example is the ‘saved lives’ metrics which the Bloomberg 
and Gates foundations regularly use to assess which parts of the Initiative are working and 
which ones are not. This new type of metrics is based on complex computer simulation 
models which combine into one numerical estimate all the different data captured by the 
Initiative’s audit and surveillance systems – Bloomberg and Gates’s investments, the 
grantees’ self-reported activities, national tobacco control laws, smoking prevalence rates 
and the like. Another great example is the figure of the professional advocate who is not 
just passionate about tobacco control and global health but also fully trained in project 
management – from filling in time sheets and writing up reports to managing a budget and 
running an organisation. This new type of subject emerges out of what Gilles Deleuze (1992, 
p.7) in his Postscript on the Societies of Control would call the ‘continuous forms of control’ 
and the ‘perpetual training’ logic associated with the Initiative – the constant self-
recording and reporting; the regular inspections during which accountants and 
management experts offer advice and counsel on how to organise and work; and the 
training courses in project management and accounting (see also Jensen and Winthereik, 
2013).  
 
Another aspect of epidemiological accountability that I would like to emphasise is the way 
it has transformed audit from a profit-making tool of late twentieth century corporate 
capitalism into a biopolitical instrument of modern philanthropy. This transformation is 
particularly evident when one compares the culture of corporate accountability that Bill 
Gates put in place at Microsoft with the practices of epidemiological accountability 
permeating the Initiative. As I suggested in the article, both share similar audit techniques 
and expertise. Indeed, like Bloomberg and other philanthropists, Bill Gates made very clear 
that he wanted to bring his business acumen and know-how – including and especially his 
belief in data and audit practices – into his philanthropic work. But, as he made clear 
himself, there is an important difference between the audit practices used at Microsoft 
and those at work within the Initiative: at Microsoft, audit practices are a tool for making 
profit; in the Initiative, these same practices are an instrument to save lives – an audit of 
saving lives, if you will. This shift from profit making to saving lives is made possible by the 
combination of audit practices with epidemiological techniques that is so characteristic of 
epidemiological accountability. An excellent illustration is the computer simulation models 
mentioned in the previous paragraph, which associate the grantees’ activities captured 
through audit and the numbers of lives saved measured through epidemiological proxies 
like smoking prevalence. It is worth noting that the way epidemiological accountability de-
couples audit practices from profit and re-couples them with life directly contradicts the 
claim made by anthropologist Susan Erikson (2016) that the private turn in global health 
has transformed health metrics into tools for profit-making. It also worth emphasising that 
epidemiological accountability differs from the audit practices permeating international 
development described by Rottenburg (2000) and others (e.g. Merry, 2011; Jensen and 
Winthereik, 2013). Indeed, as some commentators have pointed out (Edwards and Hulme, 
1996, p.968; see also Fowler, 1996), the audit practices deployed in the field of 
development often have ‘no obvious bottom line’ – a consequence of having been de-
coupled from the profit motive but not re-coupled with other measures of success, in 
contrast to epidemiological accountability.  
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To finish, I would like to reflect on the figure of the accountee in epidemiological 
accountability and, in this way, return to the body of literature critiquing philanthropies’ 
lack of accountability explored at the start of the article.4 All forms of accountability 
presume a particular kind of accountee, that is an imagined public or group of persons to 
whom one has to give account and who will appraise this account (Power, 1997; Bovens, 
2006; Hesselmann, 2011). To capture the specific nature of the imagined public of 
epidemiological accountability in the Initiative, I want to compare it with the figures of the 
accountee informing two other forms of accountability: corporate accountability at 
Microsoft when Bill Gates was CEO; and democratic accountability in New York City when 
Michael Bloomberg was Mayor. At Microsoft, the accountees are the shareholders or 
investors: they read the company’s annual reports to assess whether their investments are 
profitable and, if not, they divest. In Bloomberg’s New York, the accountees are the 
citizens: they examine the Public Report Cards issued by the Mayor and, if they are 
dissatisfied with the way he runs the city, they vote him out. In contrast to Microsoft’s 
investors and New York’s citizens, the imagined publics of the Bloomberg Initiative are 
global health experts. These experts can examine the epidemiological and audit data 
collected for the Initiative, much of which is made public in documents like the Bloomberg 
and Gates foundations’ annual reports, the WHO’s Reports on the Global Tobacco 
Epidemic and the CDC’s Global Adult Tobacco Surveys. And, if they have concerns, they 
can voice these in reasoned critiques published in academic journals or presented at 
scientific conferences. An excellent and, for some, perhaps unexpected example is the 
very commentators who have critiqued philanthropies’ lack of accountability and whose 
work we examined at the beginning. Indeed, these commentators – like The Lancet editor 
Richard Horton and Oxford professor David Stuckler – are prominent global health experts 
who have developed and published in leading journals sophisticated and powerful 
critiques of philanthropies like the Gates and Bloomberg foundations. Contrary to what 
they seem to think, it is them and their reasoned critiques – rather than an elusive world 
citizenry and a utopian global democratic system – that can and already have forced 
philanthropists to listen and change the way they work.   
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1. Commentators who bemoan the lack of transparency and accountability displayed by philanthropies 
working in global health do not usually employ the term ‘social accountability’, preferring instead the 
expressions ‘democratic’ or ‘public accountability’ (e.g. Rushton and Williams, 2011, p.18; McCoy and 
McGoey, 2011, p.157). However, there is no doubt that what these commentators have in mind when 
they speak about ‘democratic’ or ‘public accountability’ is the same thing as what the World Bank and 
many development experts like to call ‘social accountability’ (Malena et al., 2004). 
 
2. This research project draws on three different types of data: (1) articles, books, reports, pamphlets and 
other documents authored by individuals and organisations associated with the Bloomberg Initiative in 
one way or another; (2) semi-structured interviews with over 100 experts, activists, managers and other 
individuals working for or otherwise involved with the Initiative; and (3) ethnographic observations 
recorded at workshops, meetings and other events related to the Initiative and attended by the author. 
This corpus of texts, interviews and notes was examined to identify and make sense of the cultures and 
practices of accountability that inform and shape the organisation and management of the Initiative 
(see Latour, 1993; Hine, 2007; Prainsack and Wahlberg, 2013). 
 
3. In late 2014, the Gates Foundation sold its shares in Coca-Cola and McDonald’s, keeping however its 
holdings in other big players within the alcohol and food industry (Cohen, 2015). 
 
4. Accountee is a term that I have coined to describe the group of persons to whom one has to give account 
and who will pass judgement on this account. It is synonym with ‘principal’, ‘accountability taker’ and 
‘accountability forum’, which are the terms generally used in the specialised literature on accountability 
but which I found uninformative, confusing and/or somewhat inelegant (Power, 1997; Bovens, 2006; 
Hesselmann, 2011). I coined the term by amalgamating ‘account’ with the suffix ‘–ee’. According to the 
Oxford English Dictionary, the suffix ‘–ee’ comes from the Anglo-Norman and Old French ‘–é’ and has 
been ‘freely added to English verb stems to form nouns denoting the passive party’ while, at the same 
time and in contrast, the prefix ‘–or’ has been added to the same verb stems to denote the active agent, 
as in grantee/grantor, trustee/trustor and tutee/tutor. By the same logic, the person who gives account 
could be termed the accountor.   
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Figure 1. Headquarters of Bloomberg Philanthropies located off 
Park Avenue in New York City’s Upper East Side. 
 
 
Figure 2. Advocacy Activity Log developed for the African Tobacco Control Consortium 
led by the American Cancer Society and funded by the Gates Foundation. 
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Figure 3. Graph taken from the WHO’s 2013 Report on the Global Tobacco 
Epidemic showing the percentage of the world’s population covered by 
MPOWER policies. 
 
 
 
 
Figure 4. A Bloomberg Philanthropies’ senior health expert presenting 
the Initiative to grantees at the New York Headquarters of Bloomberg 
L.P. 
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Figure 5. Image taken from a 2011 report by Bloomberg Philanthropies.  
 
 
